25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Genolution Inc.
Buy, Hold or Sell?

Let's analyze Genolution Inc. together

I guess you are interested in Genolution Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genolution Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Genolution Inc.

I send you an email if I find something interesting about Genolution Inc..

1. Quick Overview

1.1. Quick analysis of Genolution Inc. (30 sec.)










1.2. What can you expect buying and holding a share of Genolution Inc.? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
37.5%

What is your share worth?

Current worth
₩4,569.63
Expected worth in 1 year
₩3,734.39
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
₩-835.24
Return On Investment
-29.2%

For what price can you sell your share?

Current Price per Share
₩2,865.00
Expected price per share
₩2,405 - ₩3,160
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Genolution Inc. (5 min.)




Live pricePrice per Share (EOD)
₩2,865.00

2.2. Growth of Genolution Inc. (5 min.)




Is Genolution Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$57.7m$67.2m-$7.3m-12.4%

How much money is Genolution Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$825.5k-$409.7k-33.2%
Net Profit Margin-96.4%-38.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Genolution Inc. (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Genolution Inc.?

Welcome investor! Genolution Inc.'s management wants to use your money to grow the business. In return you get a share of Genolution Inc..

First you should know what it really means to hold a share of Genolution Inc.. And how you can make/lose money.

Speculation

The Price per Share of Genolution Inc. is ₩2,865. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genolution Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genolution Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩4,569.63. Based on the TTM, the Book Value Change Per Share is ₩-208.81 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-49.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genolution Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.120.0%-0.070.0%-0.050.0%0.170.0%0.170.0%
Usd Book Value Change Per Share-0.130.0%-0.150.0%-0.030.0%0.200.0%0.200.0%
Usd Dividend Per Share0.000.0%0.000.0%0.020.0%0.040.0%0.040.0%
Usd Total Gains Per Share-0.130.0%-0.150.0%-0.020.0%0.240.0%0.240.0%
Usd Price Per Share2.18-2.56-5.03-9.37-9.37-
Price to Earnings Ratio-4.51-157.16-3.41-36.56-36.56-
Price-to-Total Gains Ratio-17.05--20.21--122.15--12.69--12.69-
Price to Book Ratio0.68-0.77-1.37-3.43-3.43-
Price-to-Total Gains Ratio-17.05--20.21--122.15--12.69--12.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.0055
Number of shares498
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.150.20
Usd Total Gains Per Share-0.150.24
Gains per Quarter (498 shares)-72.79120.48
Gains per Year (498 shares)-291.17481.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-291-30184398472
20-582-592167796954
30-873-88325111951436
40-1165-117433515931918
50-1456-146541819912400
60-1747-175650223892882
70-2038-204758627883364
80-2329-233866931863846
90-2620-262975335844328
100-2912-292083739824810

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.02.00.033.3%6.05.00.054.5%11.05.00.068.8%11.05.00.068.8%11.05.00.068.8%
Book Value Change Per Share0.03.00.00.0%4.07.00.036.4%9.07.00.056.3%9.07.00.056.3%9.07.00.056.3%
Dividend per Share0.00.03.00.0%4.00.07.036.4%6.00.010.037.5%6.00.010.037.5%6.00.010.037.5%
Total Gains per Share0.03.00.00.0%5.06.00.045.5%10.06.00.062.5%10.06.00.062.5%10.06.00.062.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Genolution Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---182.429-208.810+14%-49.163-73%285.602-164%285.602-164%
Book Value Per Share--4569.6334733.765-3%5234.577-13%4632.787-1%4632.787-1%
Current Ratio--3.4103.879-12%15.430-78%7.406-54%7.406-54%
Debt To Asset Ratio--0.2490.240+4%0.171+46%0.205+22%0.205+22%
Debt To Equity Ratio--0.3320.317+5%0.206+61%0.262+27%0.262+27%
Dividend Per Share----0%25.063-100%60.004-100%60.004-100%
Enterprise Value--28795760750.00039104507460.000-26%146757465870.000-80%258697784185.700-89%258697784185.700-89%
Eps---172.557-97.735-43%-64.906-62%240.947-172%240.947-172%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--4.2586.108-30%12.354-66%7.732-45%7.732-45%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap51730440000.000-9%56154237750.00066085051500.000-15%131787504137.500-57%242357133228.825-77%242357133228.825-77%
Net Profit Margin---1.843-0.964-48%-0.387-79%-0.001-100%-0.001-100%
Operating Margin----0%-0%0.120-100%0.120-100%
Operating Ratio--1.3282.580-49%1.644-19%1.110+20%1.110+20%
Pb Ratio0.627-9%0.6810.772-12%1.368-50%3.429-80%3.429-80%
Pe Ratio-4.151+8%-4.506157.161-103%3.414-232%36.562-112%36.562-112%
Price Per Share2865.000-9%3110.0003660.000-15%7183.750-57%13385.313-77%13385.313-77%
Price To Free Cash Flow Ratio----3.0290%-3.1280%4.534-100%4.534-100%
Price To Total Gains Ratio-15.705+8%-17.048-20.213+19%-122.153+617%-12.694-26%-12.694-26%
Quick Ratio---2.106-100%23.574-100%9.620-100%9.620-100%
Return On Assets---0.028-0.016-44%-0.010-64%0.050-157%0.050-157%
Return On Equity---0.038-0.021-44%-0.012-67%0.065-158%0.065-158%
Total Gains Per Share---182.429-208.810+14%-24.100-87%345.607-153%345.607-153%
Usd Book Value--57756587.70059831086.588-3%67226275.499-14%58885767.703-2%58885767.703-2%
Usd Book Value Change Per Share---0.128-0.146+14%-0.034-73%0.200-164%0.200-164%
Usd Book Value Per Share--3.1993.314-3%3.664-13%3.243-1%3.243-1%
Usd Dividend Per Share----0%0.018-100%0.042-100%0.042-100%
Usd Enterprise Value--20157032.52527373155.222-26%102730226.109-80%181088448.930-89%181088448.930-89%
Usd Eps---0.121-0.068-43%-0.045-62%0.169-172%0.169-172%
Usd Free Cash Flow----1958166.1240%-866120.0150%3584462.906-100%3584462.906-100%
Usd Market Cap36211308.000-9%39307966.42546259536.050-15%92251252.896-57%169649993.260-77%169649993.260-77%
Usd Price Per Share2.006-9%2.1772.562-15%5.029-57%9.370-77%9.370-77%
Usd Profit---2180983.000-1235296.221-43%-825519.510-62%3046161.837-172%3046161.837-172%
Usd Revenue--1183510.3001168869.464+1%1983559.615-40%8145473.573-85%8145473.573-85%
Usd Total Gains Per Share---0.128-0.146+14%-0.017-87%0.242-153%0.242-153%
 EOD+3 -4MRQTTM+10 -19YOY+5 -265Y+4 -3010Y+4 -30

3.3 Fundamental Score

Let's check the fundamental score of Genolution Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.151
Price to Book Ratio (EOD)Between0-10.627
Net Profit Margin (MRQ)Greater than0-1.843
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than13.410
Debt to Asset Ratio (MRQ)Less than10.249
Debt to Equity Ratio (MRQ)Less than10.332
Return on Equity (MRQ)Greater than0.15-0.038
Return on Assets (MRQ)Greater than0.05-0.028
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Genolution Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.273
Ma 20Greater thanMa 502,660.250
Ma 50Greater thanMa 1002,414.300
Ma 100Greater thanMa 2002,656.950
OpenGreater thanClose2,830.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Genolution Inc.

Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits. It also provides siRNA/shRNA synthesis service to inhibit gene expression and other gene related services; and long dsRNA synthesis service to inhibit gene expression by injecting RNA into various living organisms. The company was founded in 2006 and is based in Seoul, South Korea.

Fundamental data was last updated by Penke on 2025-02-03 10:38:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Genolution Inc. earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Genolution Inc. to the Biotechnology industry mean.
  • A Net Profit Margin of -184.3% means that ₩-1.84 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genolution Inc.:

  • The MRQ is -184.3%. The company is making a huge loss. -2
  • The TTM is -96.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-184.3%TTM-96.4%-87.9%
TTM-96.4%YOY-38.7%-57.6%
TTM-96.4%5Y-0.1%-96.3%
5Y-0.1%10Y-0.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-184.3%-101.2%-83.1%
TTM-96.4%-211.9%+115.5%
YOY-38.7%-209.8%+171.1%
5Y-0.1%-342.2%+342.1%
10Y-0.1%-488.9%+488.8%
4.3.1.2. Return on Assets

Shows how efficient Genolution Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genolution Inc. to the Biotechnology industry mean.
  • -2.8% Return on Assets means that Genolution Inc. generated ₩-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genolution Inc.:

  • The MRQ is -2.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.8%TTM-1.6%-1.2%
TTM-1.6%YOY-1.0%-0.6%
TTM-1.6%5Y5.0%-6.6%
5Y5.0%10Y5.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.8%-12.3%+9.5%
TTM-1.6%-12.3%+10.7%
YOY-1.0%-11.8%+10.8%
5Y5.0%-13.3%+18.3%
10Y5.0%-15.3%+20.3%
4.3.1.3. Return on Equity

Shows how efficient Genolution Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genolution Inc. to the Biotechnology industry mean.
  • -3.8% Return on Equity means Genolution Inc. generated ₩-0.04 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genolution Inc.:

  • The MRQ is -3.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.8%TTM-2.1%-1.7%
TTM-2.1%YOY-1.2%-0.9%
TTM-2.1%5Y6.5%-8.6%
5Y6.5%10Y6.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.8%-15.8%+12.0%
TTM-2.1%-16.9%+14.8%
YOY-1.2%-15.2%+14.0%
5Y6.5%-19.5%+26.0%
10Y6.5%-20.7%+27.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Genolution Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Genolution Inc. is operating .

  • Measures how much profit Genolution Inc. makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genolution Inc. to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genolution Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y12.0%-12.0%
5Y12.0%10Y12.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--201.5%+201.5%
TTM--316.3%+316.3%
YOY--217.2%+217.2%
5Y12.0%-367.6%+379.6%
10Y12.0%-489.8%+501.8%
4.3.2.2. Operating Ratio

Measures how efficient Genolution Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.33 means that the operating costs are ₩1.33 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Genolution Inc.:

  • The MRQ is 1.328. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.580. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.328TTM2.580-1.252
TTM2.580YOY1.644+0.936
TTM2.5805Y1.110+1.471
5Y1.11010Y1.1100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3282.160-0.832
TTM2.5803.220-0.640
YOY1.6443.247-1.603
5Y1.1104.740-3.630
10Y1.1106.440-5.330
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Genolution Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Genolution Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.41 means the company has ₩3.41 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Genolution Inc.:

  • The MRQ is 3.410. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.879. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.410TTM3.879-0.469
TTM3.879YOY15.430-11.551
TTM3.8795Y7.406-3.527
5Y7.40610Y7.4060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4103.610-0.200
TTM3.8793.865+0.014
YOY15.4304.596+10.834
5Y7.4065.968+1.438
10Y7.4066.183+1.223
4.4.3.2. Quick Ratio

Measures if Genolution Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genolution Inc. to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genolution Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.106-2.106
TTM2.106YOY23.574-21.468
TTM2.1065Y9.620-7.514
5Y9.62010Y9.6200.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.035-3.035
TTM2.1063.357-1.251
YOY23.5744.345+19.229
5Y9.6205.954+3.666
10Y9.6206.490+3.130
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Genolution Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Genolution Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genolution Inc. to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Genolution Inc. assets are financed with 24.9% credit (debt) and the remaining percentage (100% - 24.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genolution Inc.:

  • The MRQ is 0.249. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.240. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.249TTM0.240+0.009
TTM0.240YOY0.171+0.069
TTM0.2405Y0.205+0.035
5Y0.20510Y0.2050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2490.341-0.092
TTM0.2400.343-0.103
YOY0.1710.316-0.145
5Y0.2050.364-0.159
10Y0.2050.384-0.179
4.5.4.2. Debt to Equity Ratio

Measures if Genolution Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genolution Inc. to the Biotechnology industry mean.
  • A Debt to Equity ratio of 33.2% means that company has ₩0.33 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genolution Inc.:

  • The MRQ is 0.332. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.317. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.332TTM0.317+0.015
TTM0.317YOY0.206+0.111
TTM0.3175Y0.262+0.055
5Y0.26210Y0.2620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3320.385-0.053
TTM0.3170.428-0.111
YOY0.2060.391-0.185
5Y0.2620.450-0.188
10Y0.2620.492-0.230
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Genolution Inc. generates.

  • Above 15 is considered overpriced but always compare Genolution Inc. to the Biotechnology industry mean.
  • A PE ratio of -4.51 means the investor is paying ₩-4.51 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genolution Inc.:

  • The EOD is -4.151. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.506. Based on the earnings, the company is expensive. -2
  • The TTM is 157.161. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.151MRQ-4.506+0.355
MRQ-4.506TTM157.161-161.667
TTM157.161YOY3.414+153.747
TTM157.1615Y36.562+120.599
5Y36.56210Y36.5620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.151-2.274-1.877
MRQ-4.506-2.779-1.727
TTM157.161-3.256+160.417
YOY3.414-3.350+6.764
5Y36.562-6.153+42.715
10Y36.562-6.762+43.324
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genolution Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-3.029+3.029
TTM-3.029YOY-3.128+0.099
TTM-3.0295Y4.534-7.562
5Y4.53410Y4.5340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.606+3.606
TTM-3.029-3.837+0.808
YOY-3.128-4.520+1.392
5Y4.534-8.200+12.734
10Y4.534-9.265+13.799
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Genolution Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.68 means the investor is paying ₩0.68 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Genolution Inc.:

  • The EOD is 0.627. Based on the equity, the company is cheap. +2
  • The MRQ is 0.681. Based on the equity, the company is cheap. +2
  • The TTM is 0.772. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.627MRQ0.681-0.054
MRQ0.681TTM0.772-0.091
TTM0.772YOY1.368-0.596
TTM0.7725Y3.429-2.657
5Y3.42910Y3.4290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6271.905-1.278
MRQ0.6812.242-1.561
TTM0.7722.437-1.665
YOY1.3682.470-1.102
5Y3.4293.744-0.315
10Y3.4294.444-1.015
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302024-03-312024-06-302024-09-30
Operating Income  -2,230,908774,888-1,456,020-710,731-2,166,752-254,559-2,421,3102,989,121567,811



6.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets109,867,888
Total Liabilities27,358,477
Total Stockholder Equity82,359,960
 As reported
Total Liabilities 27,358,477
Total Stockholder Equity+ 82,359,960
Total Assets = 109,867,888

Assets

Total Assets109,867,888
Total Current Assets39,275,612
Long-term Assets70,592,276
Total Current Assets
Total Current Assets  (as reported)39,275,612
Total Current Assets  (calculated)0
+/- 39,275,612
Long-term Assets
Long-term Assets  (as reported)70,592,276
Long-term Assets  (calculated)0
+/- 70,592,276

Liabilities & Shareholders' Equity

Total Current Liabilities11,518,581
Long-term Liabilities15,839,897
Total Stockholder Equity82,359,960
Total Current Liabilities
Total Current Liabilities  (as reported)11,518,581
Total Current Liabilities  (calculated)0
+/- 11,518,581
Long-term Liabilities
Long-term Liabilities  (as reported)15,839,897
Long-term Liabilities  (calculated)0
+/- 15,839,897
Total Stockholder Equity
Total Stockholder Equity (as reported)82,359,960
Total Stockholder Equity (calculated)0
+/- 82,359,960
Other
Common Stock Shares Outstanding 18,056
Net Invested Capital 82,359,960
Net Working Capital 27,757,031



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-03-31
> Total Assets 
0
64,231,185
83,773,905
92,161,137
96,834,535
101,262,727
94,941,433
109,690,255
119,211,026
122,597,226
114,453,735
114,883,017
117,831,059
116,094,226
114,774,581
112,718,105
109,867,888
109,867,888112,718,105114,774,581116,094,226117,831,059114,883,017114,453,735122,597,226119,211,026109,690,25594,941,433101,262,72796,834,53592,161,13783,773,90564,231,1850
   > Total Current Assets 
0
47,657,801
63,447,973
69,608,003
69,349,016
71,150,171
57,667,076
68,820,293
59,511,200
62,417,640
54,542,332
52,576,520
53,430,226
49,687,020
46,565,457
43,959,048
39,275,612
39,275,61243,959,04846,565,45749,687,02053,430,22652,576,52054,542,33262,417,64059,511,20068,820,29357,667,07671,150,17169,349,01669,608,00363,447,97347,657,8010
       Cash And Cash Equivalents 
0
30,611,900
43,956,608
40,220,104
45,719,116
45,383,753
2,978
1,875
1,346
2,140
12,450
15,443
13,921
6,570,189
5,705,857
7,195,670
0
07,195,6705,705,8576,570,18913,92115,44312,4502,1401,3461,8752,97845,383,75345,719,11640,220,10443,956,60830,611,9000
       Short-term Investments 
0
5,150,000
5,000,000
15,000,001
15,035,175
15,159,133
12,019,416
10,020,486
10,000,000
42,261,200
39,078,700
39,737,536
42,749,860
36,702,430
35,316,006
32,100,678
0
032,100,67835,316,00636,702,43042,749,86039,737,53639,078,70042,261,20010,000,00010,020,48612,019,41615,159,13315,035,17515,000,0015,000,0005,150,0000
       Net Receivables 
0
8,256,295
9,048,465
10,051,355
4,666,799
6,666,103
7,705,667
13,054,531
3,441,348
3,378,061
2,892,412
999,805
1,319,758
1,076,400
814,748
1,286,965
0
01,286,965814,7481,076,4001,319,758999,8052,892,4123,378,0613,441,34813,054,5317,705,6676,666,1034,666,79910,051,3559,048,4658,256,2950
       Other Current Assets 
0
1,243,819
857,447
1,656,140
802,524
956,193
0
10,000
10,001
10,000
10,000
790,000
790,000
0
1
1
0
0110790,000790,00010,00010,00010,00110,0000956,193802,5241,656,140857,4471,243,8190
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
60,179,586
59,911,403
62,306,497
64,400,834
66,407,205
68,209,124
68,759,057
70,592,276
70,592,27668,759,05768,209,12466,407,20564,400,83462,306,49759,911,40360,179,586000000000
       Property Plant Equipment 
0
14,683,210
16,089,815
16,829,101
17,931,145
21,024,617
21,383,899
23,421,870
42,394,728
42,623,655
42,570,635
42,504,356
43,858,009
46,581,977
50,278,972
55,568,816
0
055,568,81650,278,97246,581,97743,858,00942,504,35642,570,63542,623,65542,394,72823,421,87021,383,89921,024,61717,931,14516,829,10116,089,81514,683,2100
       Intangible Assets 
0
546,418
850,633
881,424
884,665
880,205
875,746
871,286
905,079
444,236
437,832
450,371
448,673
308,786
336,791
328,239
0
0328,239336,791308,786448,673450,371437,832444,236905,079871,286875,746880,205884,665881,424850,633546,4180
       Other Assets 
0
818,407
839,310
281,009
202,263
223,785
922,378
973,644
880,524
914,506
1,212,519
3,859,612
3,552,000
0
0
0
0
00003,552,0003,859,6121,212,519914,506880,524973,644922,378223,785202,263281,009839,310818,4070
> Total Liabilities 
0
18,966,417
22,482,664
22,785,252
19,543,863
18,160,077
12,738,160
17,025,138
23,862,502
23,748,037
19,754,935
16,787,814
21,375,438
21,193,704
26,668,411
26,914,744
27,358,477
27,358,47726,914,74426,668,41121,193,70421,375,43816,787,81419,754,93523,748,03723,862,50217,025,13812,738,16018,160,07719,543,86322,785,25222,482,66418,966,4170
   > Total Current Liabilities 
0
11,819,974
15,835,788
15,894,949
12,512,335
17,616,531
12,648,838
16,747,829
8,624,443
8,239,074
4,643,596
1,589,853
6,189,381
6,006,552
10,885,711
11,131,368
11,518,581
11,518,58111,131,36810,885,7116,006,5526,189,3811,589,8534,643,5968,239,0748,624,44316,747,82912,648,83817,616,53112,512,33515,894,94915,835,78811,819,9740
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
4,500,000
0
0
0
0
00004,500,000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
1,727,523
1,786,953
0
4,500,000
4,500,000
9,000,000
9,000,000
0
09,000,0009,000,0004,500,0004,500,00001,786,9531,727,523000000000
       Accounts payable 
0
624,222
601,916
538,721
0
0
0
0
0
416,668
191,664
111,259
228,381
113,154
66,035
168,225
0
0168,22566,035113,154228,381111,259191,664416,66800000538,721601,916624,2220
       Other Current Liabilities 
0
11,047,524
14,970,854
15,094,641
0
0
0
0
0
-1
-1
0
0
0
0
1
0
010000-1-10000015,094,64114,970,85411,047,5240
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
15,508,962
15,111,339
15,197,961
15,186,057
15,187,152
15,782,700
15,783,376
15,839,897
15,839,89715,783,37615,782,70015,187,15215,186,05715,197,96115,111,33915,508,962000000000
       Long term Debt Total 
0
6,296,680
6,646,876
6,646,876
6,646,876
0
0
22,482
15,020,335
15,049,189
15,059,288
15,044,754
15,089,102
0
0
0
0
000015,089,10215,044,75415,059,28815,049,18915,020,33522,482006,646,8766,646,8766,646,8766,296,6800
       Other Liabilities 
0
849,763
0
243,427
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000243,4270849,7630
> Total Stockholder Equity
0
45,264,767
61,291,241
69,375,885
77,290,671
83,102,650
82,203,272
92,665,117
95,348,524
98,849,189
94,698,800
98,095,202
96,455,622
94,900,522
87,690,169
85,475,649
82,359,960
82,359,96085,475,64987,690,16994,900,52296,455,62298,095,20294,698,80098,849,18995,348,52492,665,11782,203,27283,102,65077,290,67169,375,88561,291,24145,264,7670
   Common Stock
0
2,351,795
2,391,795
2,391,795
4,783,590
4,783,590
4,783,590
4,783,590
4,783,590
4,795,418
4,795,418
4,961,754
9,595,011
0
0
0
0
00009,595,0114,961,7544,795,4184,795,4184,783,5904,783,5904,783,5904,783,5904,783,5902,391,7952,391,7952,351,7950
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 00000000000000000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
576,808
591,277
32,416,304
30,011,793
27,653,996
22,075,209
22,083,681
22,082,946
22,401,363
21,001,946
23,673,110
19,130,811
0
0
0
0
000019,130,81123,673,11021,001,94622,401,36322,082,94622,083,68122,075,20927,653,99630,011,79332,416,304591,277576,8080



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue9,761,301
Cost of Revenue-5,240,156
Gross Profit4,521,1464,521,146
 
Operating Income (+$)
Gross Profit4,521,146
Operating Expense-16,852,688
Operating Income-7,091,386-12,331,542
 
Operating Expense (+$)
Research Development3,081,400
Selling General Administrative2,079,306
Selling And Marketing Expenses0
Operating Expense16,852,6885,160,706
 
Net Interest Income (+$)
Interest Income1,835,346
Interest Expense-0
Other Finance Cost-1
Net Interest Income1,835,347
 
Pretax Income (+$)
Operating Income-7,091,386
Net Interest Income1,835,347
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,653,181-7,091,386
EBIT - interestExpense = 0
-5,511,619
-5,511,619
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-6,653,181
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-6,653,181
Tax Provision--1,102,809
Net Income From Continuing Ops-5,550,372-5,550,372
Net Income-5,511,619
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,835,347
 

Technical Analysis of Genolution Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genolution Inc.. The general trend of Genolution Inc. is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genolution Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genolution Inc..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2,890 < 3,090 < 3,160.

The bearish price targets are: 2,780 > 2,505 > 2,405.

Tweet this
Genolution Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genolution Inc.. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genolution Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genolution Inc.. The current macd is 114.84.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Genolution Inc. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Genolution Inc.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Genolution Inc. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Genolution Inc. Daily Moving Average Convergence/Divergence (MACD) ChartGenolution Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genolution Inc.. The current adx is 43.49.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genolution Inc. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Genolution Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genolution Inc.. The current sar is 2,369.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Genolution Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genolution Inc.. The current rsi is 68.27. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Genolution Inc. Daily Relative Strength Index (RSI) ChartGenolution Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genolution Inc.. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Genolution Inc. price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Genolution Inc. Daily Stochastic Oscillator ChartGenolution Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genolution Inc.. The current cci is 139.71.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Genolution Inc. Daily Commodity Channel Index (CCI) ChartGenolution Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genolution Inc.. The current cmo is 44.84.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Genolution Inc. Daily Chande Momentum Oscillator (CMO) ChartGenolution Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genolution Inc.. The current willr is -6.94444444.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Genolution Inc. Daily Williams %R ChartGenolution Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genolution Inc..

Genolution Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genolution Inc.. The current atr is 138.22.

Genolution Inc. Daily Average True Range (ATR) ChartGenolution Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genolution Inc.. The current obv is 9,432,518.

Genolution Inc. Daily On-Balance Volume (OBV) ChartGenolution Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genolution Inc.. The current mfi is 71.51.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Genolution Inc. Daily Money Flow Index (MFI) ChartGenolution Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genolution Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Genolution Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genolution Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.273
Ma 20Greater thanMa 502,660.250
Ma 50Greater thanMa 1002,414.300
Ma 100Greater thanMa 2002,656.950
OpenGreater thanClose2,830.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Genolution Inc. with someone you think should read this too:
  • Are you bullish or bearish on Genolution Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genolution Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genolution Inc.

I send you an email if I find something interesting about Genolution Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Genolution Inc..

Receive notifications about Genolution Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.